| BTAI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BTAI shares outstanding history going back to 3/8/2018:
Also see: BTAI Market Cap History BTAI YTD Return |
BTAI Shares Outstanding History — BioXcel Therapeutics Share Count Over Time
As of 3/26/2026 BioXcel Therapeutics has 27.07 million BTAI shares outstanding. Investors often track the BTAI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BTAI share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 3/8/2018.
| BTAI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BTAI Historical Shares Outstanding: +51.60% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BTAI Stock Price Chart |
| About BioXcel Therapeutics Inc |
| BioXcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence to develop medicines in neuroscience and immuno-oncology through its subsidiary, OnkosXcel Therapeutics. Co.'s neuroscience candidate, BXCL501, is an investigational, orally dissolving film for treating agitation in psychiatric and neurological disorders, including bipolar disorders, schizophrenia and Alzheimer's-related dementia, for both at-home and care facility settings. Co.'s immuno-oncology candidate, BXCL701, is an oral innate immune activator aimed at treating aggressive prostate cancer, pancreatic cancer and other solid and liquid tumors. We show 33 historical shares outstanding datapoints in our coverage of BTAI's shares outstanding history. Understanding the changing numbers of BTAI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BTAI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BTAI by allowing them to research BTAI shares outstanding history as well as any other stock in our coverage universe. |
| BTAI Current Stock Quote |
Quotes delayed 20 minutes  Free BTAI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BTAI Share Performance |
| Shares Outstanding Peers |
| BioXcel Therapeutics (BTAI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BTCY Shares Outstanding History BTSG Shares Outstanding History BUG Shares Outstanding History BUR Shares Outstanding History BVS Shares Outstanding History BWV Shares Outstanding History BXRX Shares Outstanding History CABA Shares Outstanding History CADL Shares Outstanding History CAH Shares Outstanding History More Healthcare companies » |
BTAI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
